Xelpac Premium

30 mg

100 mg

260 mg

300 mg

• Generic Name: Paclitaxel

• Product Description:
  Xelpac Premium is a chemotherapy medication containing Paclitaxel, a mitotic inhibitor used to treat various cancers including breast cancer, ovarian cancer, and non-small cell lung cancer. It works by inhibiting the normal breakdown of microtubules during cell division, thereby stopping the growth of cancer cells.

• Dosage Form:
  Intravenous (IV) infusion

• Available Strengths:
  Commonly available in 100 mg/16.7 mL or 30 mg/5 mL vials (depending on the brand presentation)

• Typical Dosage:

  • Breast Cancer (Adjuvant/Metastatic): 175 mg/m² IV over 3 hours every 3 weeks

  • Ovarian Cancer: 175 mg/m² IV over 3 hours every 3 weeks in combination with cisplatin

  • Non-Small Cell Lung Cancer (NSCLC): 135 mg/m² IV over 24 hours, or 175 mg/m² over 3 hours, with cisplatin